Lista de obras - Albert Wiegman - Dominio Público Uruguay

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

scientific article published on 01 October 2019

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

artículo científico publicado en 2004

Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia

artículo científico publicado en 2008

Carotid Intima-Media Thickness in Patients With a History of Kawasaki Disease

artículo científico publicado en 2015

Children with hypercholesterolemia of unknown cause: Value of genetic risk scores

artículo científico publicado en 2016

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

scientific article published on 15 November 2019

Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia

scientific article published on 11 April 2019

Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia

artículo científico publicado en 2013

Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease

artículo científico publicado en 2016

Drug therapy of hypercholesterolaemia in children and adolescents

artículo científico publicado en 2012

Early initiation of statin treatment in children with familial hypercholesterolaemia

artículo científico

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).

artículo científico

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia

artículo científico publicado en 2007

Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study

artículo científico publicado en 2004

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

artículo científico publicado en 2015

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe.

artículo científico publicado en 2017

Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review

scientific article published on 03 November 2018

Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia

artículo científico publicado en 2010

Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study

artículo científico publicado en 2015

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

artículo científico publicado en 2004

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations

artículo científico publicado en 2017

Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study

artículo científico publicado en 2018

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

scientific article published on 29 August 2020

Familial defective apolipoprotein B and familial hypobetalipoproteinemia in one family: two neutralizing mutations

scientific article published on 01 May 2008

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

artículo científico publicado en 2015

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

artículo científico publicado en 2013

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

artículo científico publicado en 2003

Follow-up of children diagnosed with familial hypercholesterolemia in a national genetic screening program

scientific article published on 28 January 2012

Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood

artículo científico publicado en 2015

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

artículo científico publicado en 2020

Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases

article

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome

artículo científico publicado en 2014

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

artículo científico publicado en 2014

Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk

artículo científico publicado en 2013

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

artículo científico publicado en 2013

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

article

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summary

artículo científico publicado en 2014

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

artículo científico publicado en 2014

Knowns and unknowns in the care of pediatric familial hypercholesterolemia

artículo científico publicado en 2017

Lipid Screening, Action, and Follow-up in Children and Adolescents

Lipid-lowering medications

artículo científico publicado en 2004

Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin

artículo científico publicado en 2010

Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence

artículo científico publicado en 2015

Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial

artículo científico publicado en 2005

Management of hypercholesterolemia in children

artículo científico publicado en 2014

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis

artículo científico publicado en 2004

Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children

artículo científico publicado en 2011

Novel pharmacological treatments for children and adolescents with heterozygous familial hypercholesterolemia

artículo científico publicado en 2017

Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents

artículo científico publicado en 2015

Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin

artículo científico publicado en 2006

Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia

scientific article published on 01 June 2006

Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

artículo científico publicado en 2006

Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia

artículo científico publicado en 2017

Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

artículo científico publicado en 2020

Predictive genetic testing for cardiovascular diseases: Impact on carrier children

Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries

artículo científico publicado en 2014

Refusal of medical treatment in an acute comatose patient

artículo científico publicado el 1 de enero de 2011

Regional assessment of carotid artery pulse wave velocity using compressed sensing accelerated high temporal resolution 2D CINE phase contrast cardiovascular magnetic resonance

scientific article published on 20 December 2018

Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking R

artículo científico publicado en 2018

Retraction notice to "Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia" J Clin Lipidol 9 (2015) 447

scientific article published on 01 November 2015

Screening for lysosomal acid lipase deficiency: A retrospective data mining study and evaluation of screening criteria

artículo científico publicado en 2018

Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemia

artículo científico publicado en 2016

Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia: Consequences for Cardiovascular Risk

artículo científico publicado en 2016

Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia

artículo científico publicado en 2013

Statin treatment in children with familial hypercholesterolemia: the younger, the better

artículo científico publicado en 2007

Statin use during pregnancy: a systematic review and meta-analysis

artículo científico publicado en 2012

Statins for children with familial hypercholesterolemia

artículo científico publicado en 2014

Statins for children with familial hypercholesterolemia

artículo científico publicado en 2017

Statins for children with familial hypercholesterolemia

scientific article published on 07 November 2019

Steady-state pharmacokinetics of pravastatin in children with familial hypercholesterolaemia

scientific article published on 01 January 2004

Surrogate markers of atherosclerosis: impact of statins

artículo científico publicado en 2003

Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia

artículo científico publicado en 2014

The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia

artículo científico publicado en 2003

The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study

scientific article published on 19 December 2018

Treatment of dyslipidaemia in childhood

scientific article published on April 2010

[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society]

artículo científico publicado en 2015

Lista de obras de Albert Wiegman

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia

Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia

Carotid Intima-Media Thickness in Patients With a History of Kawasaki Disease

Children with hypercholesterolemia of unknown cause: Value of genetic risk scores

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia

Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia

Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease

Drug therapy of hypercholesterolaemia in children and adolescents

Early initiation of statin treatment in children with familial hypercholesterolaemia

Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).

Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia

Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent-offspring study

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe.

Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review

Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia

Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations

Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

Familial defective apolipoprotein B and familial hypobetalipoproteinemia in one family: two neutralizing mutations

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

Follow-up of children diagnosed with familial hypercholesterolemia in a national genetic screening program

Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood

Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation: executive summary

Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

Knowns and unknowns in the care of pediatric familial hypercholesterolemia

Lipid Screening, Action, and Follow-up in Children and Adolescents

Lipid-lowering medications

Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin

Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence

Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial

Management of hypercholesterolemia in children

Measurement of arterial wall thickness as a surrogate marker for atherosclerosis

Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children

Novel pharmacological treatments for children and adolescents with heterozygous familial hypercholesterolemia

Optimizing Treatment of Familial Hypercholesterolemia in Children and Adolescents

Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin

Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia

Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels

Plasma lipoprotein(a) levels in patients with homozygous autosomal dominant hypercholesterolemia

Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

Predictive genetic testing for cardiovascular diseases: Impact on carrier children

Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries

Refusal of medical treatment in an acute comatose patient

Regional assessment of carotid artery pulse wave velocity using compressed sensing accelerated high temporal resolution 2D CINE phase contrast cardiovascular magnetic resonance

Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking R

Retraction notice to "Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia" J Clin Lipidol 9 (2015) 447

Screening for lysosomal acid lipase deficiency: A retrospective data mining study and evaluation of screening criteria

Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemia

Statin Initiation During Childhood in Patients With Familial Hypercholesterolemia: Consequences for Cardiovascular Risk

Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia

Statin treatment in children with familial hypercholesterolemia: the younger, the better

Statin use during pregnancy: a systematic review and meta-analysis

Statins for children with familial hypercholesterolemia

Statins for children with familial hypercholesterolemia

Statins for children with familial hypercholesterolemia

Steady-state pharmacokinetics of pravastatin in children with familial hypercholesterolaemia

Surrogate markers of atherosclerosis: impact of statins

Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia

The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia

The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study

Treatment of dyslipidaemia in childhood

[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society]